-
1
-
-
0033653515
-
Cholesterol crystal embolism: A recognizable cause of renal disease
-
Scolari F, Tardanico R, Zani R, et al. Cholesterol crystal embolism: a recognizable cause of renal disease. Am J Kidney Dis 2000; 36:1089-1109.
-
(2000)
Am. J. Kidney Dis.
, vol.36
, pp. 1089-1109
-
-
Scolari, F.1
Tardanico, R.2
Zani, R.3
-
2
-
-
0023617407
-
Cholesterol crystal embolisation: A review of 221 cases in the English literature
-
Fine MJ, Kapoor W, Falanga V. Cholesterol crystal embolisation: a review of 221 cases in the English literature. Angiology 1987; 42:769-784.
-
(1987)
Angiology
, vol.42
, pp. 769-784
-
-
Fine, M.J.1
Kapoor, W.2
Falanga, V.3
-
3
-
-
0037006272
-
Improvement in cholesterol emboli syndrome after iloprost therapy
-
Elinav E, Chajek-Shaul T, Stern M. Improvement in cholesterol emboli syndrome after iloprost therapy. BMJ 2002; 324(7332):268-269.
-
(2002)
BMJ
, vol.324
, Issue.7332
, pp. 268-269
-
-
Elinav, E.1
Chajek-Shaul, T.2
Stern, M.3
-
4
-
-
0032907713
-
Supportive treatment improves survival in multivisceral cholesterol crystal embolism
-
Belenfant X, Meyrier A, Jacquot C. Supportive treatment improves survival in multivisceral cholesterol crystal embolism. Am J Kidney Dis 1999; 33:840-850.
-
(1999)
Am. J. Kidney Dis.
, vol.33
, pp. 840-850
-
-
Belenfant, X.1
Meyrier, A.2
Jacquot, C.3
-
5
-
-
0033086377
-
Use of prostacyclin and its analogues in the treatment of cardiovascular disease
-
Fink AN, Frishman WH, Azizad M, Agarwal Y. Use of prostacyclin and its analogues in the treatment of cardiovascular disease. Heart Dis 1999; 1(1):29-40.
-
(1999)
Heart Dis.
, vol.1
, Issue.1
, pp. 29-40
-
-
Fink, A.N.1
Frishman, W.H.2
Azizad, M.3
Agarwal, Y.4
-
6
-
-
0023805704
-
Effects of iloprost, a prostacyclin analog derivate, on renal plasma flow, renal function, and renin-aldosterone system in humans
-
Angeli P, Gatta A, Caregaro L, et al. Effects of iloprost, a prostacyclin analog derivate, on renal plasma flow, renal function, and renin-aldosterone system in humans. Clin Pharmacol Ther 1988; 44:211-216.
-
(1988)
Clin. Pharmacol. Ther.
, vol.44
, pp. 211-216
-
-
Angeli, P.1
Gatta, A.2
Caregaro, L.3
-
7
-
-
17444433575
-
Prostaglandin I2 attenuates ischemic acute renal failure in the the rat
-
Lifschitz MD, Barnes JL. Prostaglandin I2 attenuates ischemic acute renal failure in the the rat. Am J Physiol 1984; 247(5 Pt 2):F714-F717.
-
(1984)
Am. J. Physiol.
, vol.247
, Issue.5 PART 2
-
-
Lifschitz, M.D.1
Barnes, J.L.2
-
8
-
-
0022536489
-
Amelioration of postischemic acute renal failure by prostacyclin analogue (iloprost): Long-term studies with chronically instrumented conscious dogs
-
Neumayer HH, Wagner K, Preuschof L, et al. Amelioration of postischemic acute renal failure by prostacyclin analogue (iloprost): long-term studies with chronically instrumented conscious dogs. J Cardiovasc Pharmacol 1986; 8(4):785-790.
-
(1986)
J. Cardiovasc. Pharmacol.
, vol.8
, Issue.4
, pp. 785-790
-
-
Neumayer, H.H.1
Wagner, K.2
Preuschof, L.3
-
9
-
-
0030847893
-
Effect of iloprost infusion on resistance index of patients with systemic sclerosis
-
Scorza R, Rivolta R, Mascagni B, et al. Effect of iloprost infusion on resistance index of patients with systemic sclerosis. J Rheumatol 1997; 24:1944-1948.
-
(1997)
J. Rheumatol.
, vol.24
, pp. 1944-1948
-
-
Scorza, R.1
Rivolta, R.2
Mascagni, B.3
-
10
-
-
0031657845
-
Acute oliguric renal failure associated with unilateral renal embolism: A successful treatment with iloprost
-
Levin M, Nakhoul F, Keidar Z, Green J. Acute oliguric renal failure associated with unilateral renal embolism: a successful treatment with iloprost. Am J Nephrol 1998; 18(5):444-447.
-
(1998)
Am. J. Nephrol.
, vol.18
, Issue.5
, pp. 444-447
-
-
Levin, M.1
Nakhoul, F.2
Keidar, Z.3
Green, J.4
|